[Preliminary results of clinical evaluation of antineoplastic antibiotic bleomycetin].
D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use* / Q000031:analogs & derivatives; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D005334:Fever / Q000139:chemically induced; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D009325:Nausea / Q000139:chemically induced; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy*; D014747:Vinblastine / Q000627:therapeutic use; D014839:Vomiting / Q000139:chemically induced
D001761:Bleomycin; C025703:bleomycetin; D014747:Vinblastine
Predvaritel'nye rezul'taty klinicheskogo izucheniia protivoopukholevogo antibiotika bleomitsetina.